‘Unheard of’ responses to bluebird CAR-T therapy seen in myeloma study – Reuters
Endpoints News |
'Unheard of' responses to bluebird CAR–T therapy seen in myeloma study
Reuters “This is unheard of, something that we haven't seen with any drugs approved for myeloma in this type of population. The excitement among all the myeloma providers is crazy,” said Berdeja, director of myeloma research at the Sarah Cannon Center for … Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 … BCMA-Directed bb2121 Highly Effective for Myeloma |
